Description

SUSTANCIA: CLOFENIX CMA

Contiene 75 mcg de Mircera por jeringa

00 MG BICARBONATO DE SODIO 1100

00 MG BETACAROTENO 0

Tratamiento de la anemia inducida por quimioterapia en pacientes con cáncer no mieloide

FLAGENASE VG 500MG CAP C10 TECNOFARMA SUSTANCIA: CLOFENIX CMAPRINCIPIO ACTIVO: METRONIDAZOL NISTATINA DOSIS: 500 MG FORMA FARMACUTICA: 10 CAPSULAS PRESENTACIN: 1 CAJA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products